LEAP2 and diabetes mellitus: In addition, participants with metabolic disorders such as diabetes, hyperlipidemia, and hypercholesterolemia, as well as thyroid and hypothalamic disorders that may potentially affect LEAP2 regulation (72, 73), were excluded.